Untargeted Metagenomic Investigation of the Airway Microbiome of Cystic Fibrosis Patients with Moderate-Severe Lung Disease.
airway microbiome
antibiotic resistance genes
cystic fibrosis
metagenome composition
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
04 Jul 2020
04 Jul 2020
Historique:
received:
25
05
2020
revised:
23
06
2020
accepted:
02
07
2020
entrez:
9
7
2020
pubmed:
9
7
2020
medline:
9
7
2020
Statut:
epublish
Résumé
Although the cystic fibrosis (CF) lung microbiota has been characterized in several studies, little is still known about the temporal changes occurring at the whole microbiome level using untargeted metagenomic analysis. The aim of this study was to investigate the taxonomic and functional temporal dynamics of the lower airway microbiome in a cohort of CF patients. Multiple sputum samples were collected over 15 months from 22 patients with advanced lung disease regularly attending three Italian CF Centers, given a total of 79 samples. DNA extracted from samples was subjected to shotgun metagenomic sequencing allowing both strain-level taxonomic profiling and assessment of the functional metagenomic repertoire. High inter-patient taxonomic heterogeneity was found with short-term compositional changes across clinical status. Each patient exhibited distinct sputum microbial communities at the taxonomic level, and strain-specific colonization of both traditional and atypical CF pathogens. A large core set of genes, including antibiotic resistance genes, were shared across patients despite observed differences in clinical status, and consistently detected in the lung microbiome of all subjects independently from known antibiotic exposure. In conclusion, an overall stability in the microbiome-associated genes was found despite taxonomic fluctuations of the communities.
Identifiants
pubmed: 32635564
pii: microorganisms8071003
doi: 10.3390/microorganisms8071003
pmc: PMC7409339
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fondazione per la Ricerca sulla Fibrosi Cistica
ID : FFC#19/2017
Références
PLoS One. 2012;7(9):e45001
pubmed: 23049765
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Nature. 2016 Dec 22;540(7634):544-551
pubmed: 27906159
Front Microbiol. 2012 Dec 19;3:417
pubmed: 23267351
PLoS One. 2017 Mar 2;12(3):e0172811
pubmed: 28253277
Trends Mol Med. 2019 Dec;25(12):1110-1122
pubmed: 31439509
PLoS One. 2017 Feb 7;12(2):e0170622
pubmed: 28170403
J Pediatr. 2008 Aug;153(2):S4-S14
pubmed: 18639722
Am J Respir Cell Mol Biol. 2012 Feb;46(2):127-31
pubmed: 21980056
Ann Am Thorac Soc. 2013 Jun;10(3):179-87
pubmed: 23802813
mSystems. 2018 Mar 13;3(2):
pubmed: 29556534
PLoS Comput Biol. 2012;8(6):e1002358
pubmed: 22719234
Nucleic Acids Res. 2017 Jan 4;45(D1):D566-D573
pubmed: 27789705
Genes (Basel). 2020 May 11;11(5):
pubmed: 32403302
Thorax. 2012 Oct;67(10):860-6
pubmed: 22555277
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):E2329-38
pubmed: 24843156
J Cyst Fibros. 2013 Mar;12(2):154-64
pubmed: 22951208
Future Microbiol. 2017 Dec;12:1445-1448
pubmed: 29068237
PLoS One. 2018 Mar 9;13(3):e0194060
pubmed: 29522532
Front Microbiol. 2019 Feb 26;10:212
pubmed: 30863369
Int J Mol Sci. 2017 Jul 29;18(8):
pubmed: 28758937
Microbiome. 2017 Feb 10;5(1):20
pubmed: 28187782
Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):30
pubmed: 30151191
Nature. 2010 Mar 4;464(7285):59-65
pubmed: 20203603
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Biol Direct. 2018 May 9;13(1):9
pubmed: 29743119
ISME J. 2014 Jun;8(6):1247-58
pubmed: 24401860
Ann Am Thorac Soc. 2016 Jul;13(7):1173-9
pubmed: 27078236
Eur Respir J. 2017 Nov 16;50(5):
pubmed: 29146601
Mol Ecol Resour. 2014 Mar;14(2):426-34
pubmed: 24128146
Nat Methods. 2016 May;13(5):435-8
pubmed: 26999001
PLoS One. 2012;7(4):e34605
pubmed: 22514642
Eur Respir J. 2017 Oct 5;50(4):
pubmed: 28982777
Am J Respir Crit Care Med. 2009 Nov 1;180(9):802-8
pubmed: 19729669
Genome Biol. 2014 Feb 03;15(2):R29
pubmed: 24485249
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Microbiome. 2015 Apr 01;3:12
pubmed: 25834733
Nature. 2012 Sep 13;489(7415):220-30
pubmed: 22972295
Nat Methods. 2015 Oct;12(10):902-3
pubmed: 26418763
Microbiome. 2020 Apr 2;8(1):45
pubmed: 32238195
Nat Biotechnol. 2017 Sep 12;35(9):833-844
pubmed: 28898207
J Clin Microbiol. 2014 Feb;52(2):425-37
pubmed: 24478471
Genome Res. 2017 Apr;27(4):626-638
pubmed: 28167665
PLoS One. 2016 Jun 29;11(6):e0156807
pubmed: 27355625
Eur Respir J. 2006 May;27(5):937-43
pubmed: 16707392
J Pediatr. 2017 Feb;181S:S4-S15.e1
pubmed: 28129811
Curr Opin Microbiol. 2015 Jun;25:56-66
pubmed: 26005845
J Cyst Fibros. 2005 Mar;4(1):7-26
pubmed: 15752677
PLoS One. 2015 Apr 21;10(4):e0124348
pubmed: 25898134
Front Microbiol. 2018 Apr 06;9:685
pubmed: 29681898